Joseph Rubinfeld
29Patents
13h-index
20Co-inventors
81Inventor score
Filing activity: Jun 15, 1973 → Jan 23, 2003
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6998391B2 | Method for treating diseases associated with abnormal kinase activity | Human Necessities | 80 | Expired |
| US6136846A | Formulation for paclitaxel | Performing Operations; Transporting | 63 | Expired |
| US5730969A | Method and compositions for solubilization and stabilization of polypeptides, especially proteins | Performing Operations; Transporting | 50 | Expired |
| US5602112A | Pharmaceutical formulation | Performing Operations; Transporting | 42 | Expired |
| US6319943A | Oral formulation for paclitaxel | Performing Operations; Transporting | 37 | Expired |
| US5997856A | Method and compositions for solubilization and stabilization of polypeptides, especially proteins | Performing Operations; Transporting | 36 | Expired |
| US5824668A | Formulation for administration of steroid compounds | Performing Operations; Transporting | 27 | Expired |
| US6017948A | Water-miscible pharmaceutical compositions | Human Necessities | 26 | Expired |
| US6538020B2 | Paclitaxel formulation | Performing Operations; Transporting | 22 | Expired |
| US5804568A | Pharmaceutical formulation | Performing Operations; Transporting | 17 | Expired |
| US6509370B1 | Paclitaxel formulation | Performing Operations; Transporting | 17 | Expired |
| US6710195B2 | Method for preparing and using polyoxyethylated castor oil in pharmaceutical compositions | Human Necessities | 15 | Expired |
| US6828346B2 | Methods for administration of paclitaxel | Performing Operations; Transporting | 14 | Expired |
| US6191119A | Combination therapy including 9-nitro-20(S)-camptothecin | Human Necessities | 13 | Expired |
| US6218374A | Pharmaceutical formulation | Performing Operations; Transporting | 13 | Expired |
| US6048845A | Pharmaceutical formulation | Performing Operations; Transporting | 12 | Expired |
| US6613753B2 | Restore cancer-suppressing functions to neoplastic cells through DNA hypomethylation | Human Necessities | 12 | Expired |
| US6420378B1 | Inhibition of abnormal cell proliferation with camptothecin and combinations including the same | Human Necessities | 11 | Expired |
| US6629995B1 | Camptothecin conjugates | Human Necessities | 8 | Expired |
| US6583125B2 | Formulation of nitrogen mustard | Performing Operations; Transporting | 7 | Expired |
| US6284747A | Pharmaceutical formulation | Performing Operations; Transporting | 7 | Expired |
| US4051315A | "6""-Deoxykanamycin B and 6""-deoxytobramycin" | Chemistry; Metallurgy | 7 | Expired |
| US4061603A | Detergents | Chemistry; Metallurgy | 6 | Expired |
| US6627614B1 | Sequential therapy comprising a 20(S)-camptothecin and an anthracycline | Human Necessities | 6 | Expired |
| US3952096A | Mixture of calcium carbonate and calcium-.alpha.-p-chlorophenoxyisobutyrate as an antihyperlipemic agent | Chemistry; Metallurgy | 6 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.